vs
Side-by-side financial comparison of agilon health, inc. (AGL) and CME Group (CME). Click either name above to swap in a different company.
CME Group is the larger business by last-quarter revenue ($1.9B vs $1.4B, roughly 1.3× agilon health, inc.). CME Group runs the higher net margin — 0.1% vs 0.0%, a 0.1% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs -3.0%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -2.1%).
agilon health, inc. is a U.S.-based healthcare company partnering with primary care providers to deliver value-based care solutions mainly for senior Medicare beneficiaries. It offers administrative support, clinical tools and risk management frameworks to help physicians improve patient outcomes and cut care costs, operating across over 20 U.S. states.
CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...
AGL vs CME — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.9B |
| Net Profit | $49.0K | $1.2M |
| Gross Margin | — | — |
| Operating Margin | — | 0.1% |
| Net Margin | 0.0% | 0.1% |
| Revenue YoY | -3.0% | 14.5% |
| Net Profit YoY | — | 20.7% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.4B | $1.9B | ||
| Q4 25 | $1.6B | $1.6B | ||
| Q3 25 | $1.4B | $1.5B | ||
| Q2 25 | $1.4B | $1.7B | ||
| Q1 25 | $1.5B | $1.6B | ||
| Q4 24 | $1.5B | $1.5B | ||
| Q3 24 | $1.5B | $1.6B | ||
| Q2 24 | $1.5B | $1.5B |
| Q1 26 | $49.0K | $1.2M | ||
| Q4 25 | $-188.9M | $1.2B | ||
| Q3 25 | $-110.2M | $908.0M | ||
| Q2 25 | $-104.4M | $1.0B | ||
| Q1 25 | $12.1M | $956.2M | ||
| Q4 24 | $-105.8M | $874.6M | ||
| Q3 24 | $-117.6M | $912.8M | ||
| Q2 24 | $-30.7M | $883.2M |
| Q1 26 | — | 0.1% | ||
| Q4 25 | -12.3% | 61.8% | ||
| Q3 25 | -9.1% | 63.3% | ||
| Q2 25 | -8.3% | 66.7% | ||
| Q1 25 | -1.4% | 67.5% | ||
| Q4 24 | -7.1% | 62.1% | ||
| Q3 24 | -9.2% | 64.6% | ||
| Q2 24 | -2.9% | 65.3% |
| Q1 26 | 0.0% | 0.1% | ||
| Q4 25 | -12.0% | 71.7% | ||
| Q3 25 | -7.7% | 59.1% | ||
| Q2 25 | -7.5% | 60.6% | ||
| Q1 25 | 0.8% | 58.2% | ||
| Q4 24 | -6.9% | 57.3% | ||
| Q3 24 | -8.1% | 57.6% | ||
| Q2 24 | -2.1% | 57.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.24 | ||
| Q3 25 | — | $2.49 | ||
| Q2 25 | — | $2.81 | ||
| Q1 25 | — | $2.62 | ||
| Q4 24 | — | $2.40 | ||
| Q3 24 | — | $2.50 | ||
| Q2 24 | — | $2.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $140.0M | $2.4B |
| Total DebtLower is stronger | $15.3M | $3.4B |
| Stockholders' EquityBook value | — | — |
| Total Assets | $1.5B | $202.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $140.0M | $2.4B | ||
| Q4 25 | $173.7M | $4.5B | ||
| Q3 25 | $171.7M | $2.6B | ||
| Q2 25 | $171.4M | $2.1B | ||
| Q1 25 | $136.9M | $1.5B | ||
| Q4 24 | $188.2M | $3.0B | ||
| Q3 24 | $148.2M | $2.4B | ||
| Q2 24 | $109.5M | $1.9B |
| Q1 26 | $15.3M | $3.4B | ||
| Q4 25 | $35.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $126.7M | $28.7B | ||
| Q3 25 | $306.1M | $28.2B | ||
| Q2 25 | $408.9M | $27.7B | ||
| Q1 25 | $500.3M | $27.0B | ||
| Q4 24 | $471.0M | $26.5B | ||
| Q3 24 | $574.9M | $28.2B | ||
| Q2 24 | $676.6M | $27.6B |
| Q1 26 | $1.5B | $202.0B | ||
| Q4 25 | $1.3B | $198.4B | ||
| Q3 25 | $1.6B | $187.1B | ||
| Q2 25 | $1.7B | $179.9B | ||
| Q1 25 | $1.9B | $157.8B | ||
| Q4 24 | $1.7B | $137.4B | ||
| Q3 24 | $2.1B | $137.8B | ||
| Q2 24 | $2.2B | $123.4B |
| Q1 26 | — | — | ||
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
